Related Experiment Video
Updated: Jul 17, 2026
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Genetics of coagulation: considerations for cardiac surgery
Steven T Morozowich1, Brian S Donahue, Ian J Welsby
1Division of Cardiothoracic Anesthesia and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Seminars in Cardiothoracic and Vascular Anesthesia
|January 4, 2007
Summary
Genetic variations in blood clotting factors are increasingly recognized in surgical patients. Understanding these genetic factors is crucial for predicting and managing bleeding or clotting risks, especially in cardiac surgery.
Area of Science:
- Coagulation genetics
- Perioperative medicine
- Cardiac surgery
Background:
- Genetic variants in the coagulation system have a long history.
- Modern diagnostics reveal a spectrum of coagulation factor deficiencies and polymorphic variants in surgical patients.
- Perioperative hemorrhagic and thrombotic complications pose significant risks.
Purpose of the Study:
- To review the implications of coagulation genetics on perioperative management.
- To highlight the role of genetic defects and variants in risk prediction and patient management.
- Focus on the context of cardiac surgery patients.
Main Methods:
- Review of existing literature on coagulation genetics and perioperative complications.
- Analysis of the role of specific genetic variants in surgical patient populations.
- Focus on implications for cardiac surgery.
Main Results:
- Clinicians frequently encounter patients with coagulation factor deficiencies and polymorphic variants.
- Coagulation genetic factors play a role in predicting perioperative risks.
- Understanding these genetics is key to optimizing patient management.
Conclusions:
- Coagulation genetics significantly impacts perioperative risk assessment.
- Tailored management strategies based on genetic profiles are essential for improving outcomes.
- Further research into specific variants and their clinical impact in cardiac surgery is warranted.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...